For the majority of immune cells, such as activated CD8-positive (CD8+) T cells and natural killer (NK) cells with tumor-killing effects, their relative contents in cluster A were significantly higher than those in cluster B (Figure 2A). The gene discussed is CD8A; the disease is neoplasm.